Skip to main content
. 2023 Oct 31;143(7):582–591. doi: 10.1182/blood.2023022420

Figure 2.

Figure 2.

Response to therapy. Categorical response rates in all patients (A) and according to the CXCR4 mutation status (B). MR, minor response.